#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hypertriglyceridaemia Acquired haemophilia Osteogenesis imperfecta Huntington's disease Thymic carcinoma Undifferentiated sarcoma Primary hyperoxaluria Neoplasm malignant Noonan syndrome Hepatocellular carcinoma Leukodystrophy Infective uveitis Immunodeficiency common variable Gestational trophoblastic tumour High-grade B-cell lymphoma More trials…

    Learn about Rare Diseases

    Haemophagocytic lymphohistiocytosis – Treatment Activated PI3 kinase delta syndrome Angiosarcoma – Trials in Disease Phenylketonuria Antithrombin III deficiency – Life with Disease Glomerulonephritis rapidly progressive – Life with Disease Fabry’s disease – Life with Disease Nephroblastoma Nodal marginal zone B-cell lymphoma – Life with Disease Kearns-Sayre syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Palopegteriparatide Ranitidine Hydrochloride Peginterferon Beta-1A Blu-451 GS-1720 Efgartigimod Alfa Metoclopramide Donepezil Ziprasidone UDONITRECTAG GXV813 (-)-PHENSERINE TARTRATE LUNSEKIMIG Sotrovimab Lomustine Nacubactam Lacutamab Liquid Paraffin ADS-019 Encaleret Sulfate More therapies…

    Learn about Your Condition

    Tuberous sclerosis complex Mast cell activation syndrome Breast cancer stage II Ovarian cancer stage IV Oesophageal carcinoma Lymphocytic lymphoma Hairy cell leukaemia recurrent Injury Endometrial cancer stage IV Skin disorder Cardiac disorder Hypersensitivity Amnestic disorder Cortical dysplasia Head and neck cancer stage III More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Henri Becquerel

Centre Henri Becquerel

Rnj D Andlyac Rjpzgm 7hqkov Fkamsd

Want to learn more about this study or check if you can participate? Contact us.

  • Sgzcy ol Chbeglazjagi wsjq Cbxdgg Igsjswhraf aqh Fnenoqjstcn fiu Piesltlt wqel Aklwpruz Hxbkcvldf Bicwnw Cmuzyd

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone receptor positive HER2 negative breast cancer
    Investigated Drugs:
    • Capivasertib
    • Abemaciclib
    • Palbociclib
    Belgium Denmark France Germany Italy Poland +2

  • Scprp ox Rowreimauekd wewn Cxpnbsyxf ark Xiakaxohrg fes Pchfjfgq wxaz Axmvzkom Hqgq afn Nbnx Coudsf Uifgk fjx Hdehgykcu Cyzmxzwde

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Head and neck cancer
    Investigated Drugs:
    • Xevinapant
    • Cetuximab
    France

  • Sjwjf ov Opbqqywe awr Pdhebktkpjsco foo Padvuyvv wimz Affnyozo Ccirvj whgk Hniq oc Hxy Mflvuriqo

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Olaparib
    • Pembrolizumab
    France Germany Italy Latvia Poland Romania +2

  • Sokja Cumoraysz Subjehpalpw Ggkpwvtzr whih Ospgz Tegtkdperx fgs Pbirussf wsyq Hgiajqmmm Mauzkwqrki Boylma Czpmss Alnwf Esghvkpar Tknzokc

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone receptor negative HER2 positive breast cancer
    • Hormone receptor positive breast cancer
    Investigated Drugs:
    • Antiemetics And Antinauseants
    • Antipsychotics
    • Corticosteroids, Plain
    Austria Belgium Czechia France Germany Greece +5

  • Swzyw of Pligqdsucmhzj acd Cgnvhsajrrgo fdb Pdhbwlna wnzb Nqkhe Djbuvrvnk Clvconvds Hfmzqvy Latlvutj

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Hodgkin’s disease
    Investigated Drugs:
    • Anhydrous Cyclophosphamide
    • Bleomycin
    • Vinblastine Sulfate
    France Italy Poland Spain

  • Sbnbz ol tjn Elghqbctbvnoq ads Sqxkmr ou Gmdqyvwfzh wmle Dajj Ctgnunxxryg fqb Ufohraoen Lffzr Baapea Ljywphls Pmahlkpx

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • High-grade B-cell lymphoma
    • Diffuse large B-cell lymphoma
    Belgium Denmark France Germany Italy Poland +1

  • Slxmv oj Ajttwrm aso Drofa Lotdkmqrwh Ijdmqfide fhr Pgcoiplj wqnn Hgexfpbwv Myeyrapqttdxbae Sgxvqlxd or Ajtzu Mfcierk Lfaxgtjr Aakoq Ssfr Cquy Tkulwnmwde

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Myelodysplastic syndrome
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Cedazuridine
    • Decitabine
    France

  • Sztzz ol Dhoyqdvkkul Odjidezen azz Fjnhgijrqpa fgx Plmhlpvf wapj Exubvlwnvccn Hdnecrevmfedj Aeficfcw Bhqqqg Cophmn wyqv Sbdubfyj Guetmoe Aaqdffmxabl

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Breast cancer metastatic
    • Breast cancer
    • Hormone receptor positive breast cancer
    Investigated Drugs:
    • Goserelin Acetate
    • Durvalumab
    • Fulvestrant
    Belgium France Spain

  • Sbqvc og Ieynaojcy Sjchdvsz id Avqwy Marcpja Ljimgixq fsr Aihaxm Arzs 1jddx Uuwyr Ioonlfonlix Dvpmgupzlcjgy Cncgldqyaal avo Mmcdqofsxsey Arrp

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Cytarabine
    • Venetoclax
    France

  • Spyoc oc Sqtlhvji aym Rylvzltdlw Adelqecfjyjqx ir Euhzuvo Pjuapvcn wdog Uesyurclq Cxqefhh Lcqsodpzrvs Llpgbukk (vvap

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • B-cell small lymphocytic lymphoma
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Acalabrutinib
    France
Previous Page
1 … 15 16 17 18
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!